Obesity is a medical condition caused by an increase in fat cells in the body, which can have a negative impact on health. High blood pressure, high cholesterol and heart disease are serious medical conditions associated with obesity. Obesity also increases the risk of certain diseases, such as type 2 diabetes, osteoarthritis, obstructive sleep apnea, and depression. If diet or exercise is not effective, obesity intervention devices can be used to reduce the size of the stomach or the length of the intestine, thereby reducing the ability to absorb nutrients from food.
This report contains market size and forecasts of Obesity Intervention Devices in Global, including the following market information:
Global Obesity Intervention Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Obesity Intervention Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gastric Bands Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Obesity Intervention Devices include Medtronic, EnteroMedics, Apollo Endosurgery, Cousin Biotech, Aspire Bariatrics, Obalon Therapeutics, GI Dynamics, Johnson and Johnson and Spatz FGIA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obesity Intervention Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obesity Intervention Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Obesity Intervention Devices Market Segment Percentages, by Type, 2021 (%)
Gastric Bands
Electrical Stimulation System
Gastric Balloon System
Gastric Emptying System
Appetite Suppressors
Global Obesity Intervention Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Obesity Intervention Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Gastroenterology clinics
Ambulatory Surgical Centers
Global Obesity Intervention Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Obesity Intervention Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Obesity Intervention Devices revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Obesity Intervention Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
EnteroMedics
Apollo Endosurgery
Cousin Biotech
Aspire Bariatrics
Obalon Therapeutics
GI Dynamics
Johnson and Johnson
Spatz FGIA
Gore Medical
ReShape Lifesciences